Dyanavel XR (amphetamine XR) / Tris Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dyanavel XR (amphetamine XR) / Tris Pharma
NCT04027361: Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

Completed
2
41
US
Amphetamine Extended Release (ER) Tablet 20 mg, Amphetamine extended-release oral tablet 20 mg
Tris Pharma, Inc., Massachusetts General Hospital, Massachusetts Institute of Technology
ADHD
10/21
10/21

Download Options